相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer
Pengfei Xu et al.
BIOMATERIALS (2015)
Development of individualized anti-metastasis strategies by engineering nanomedicines
Qianjun He et al.
CHEMICAL SOCIETY REVIEWS (2015)
Molecular Pathways: Targeting the CXCR4-CXCL12 Axis-Untapped Potential in the Tumor Microenvironment
Stefania Scala
CLINICAL CANCER RESEARCH (2015)
Nanotechnology for enrichment and detection of circulating tumor cells
Saheel Bhana et al.
NANOMEDICINE (2015)
Drug Carriers for the Delivery of Therapeutic Peptides
Alice W. Du et al.
BIOMACROMOLECULES (2014)
Inhibition of metastasis of rhabdomyosarcoma by a novel neutralizing antibody to CXC chemokine receptor-4
Kenji Kashima et al.
CANCER SCIENCE (2014)
Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells
Kirsten Hattermann et al.
CELL AND TISSUE RESEARCH (2014)
The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma
Amnon Peled et al.
CLINICAL CANCER RESEARCH (2014)
Endocytic trafficking of chemokine receptors
Adriano Marchese
CURRENT OPINION IN CELL BIOLOGY (2014)
Targeted delivery of doxorubicin to A549 lung cancer cells by CXCR4 antagonist conjugated PLGA nanoparticles
Chuda Chittasupho et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
PEGylation and its impact on the design of new protein-based medicines
Claire Ginn et al.
FUTURE MEDICINAL CHEMISTRY (2014)
Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin
Ling Mei et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Nanoparticle multivalency counterbalances the ligand affinity loss upon PEGylation
Robert Hennig et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Inhibiting Metastatic Breast Cancer Cell Migration via the Synergy of Targeted, pH-triggered siRNA Delivery and Chemokine Axis Blockade
Peng Guo et al.
MOLECULAR PHARMACEUTICS (2014)
A Nanoparticle-Based Combination Chemotherapy Delivery System for Enhanced Tumor Killing by Dynamic Rewiring of Signaling Pathways
Stephen W. Morton et al.
SCIENCE SIGNALING (2014)
BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic Malignancies
Michelle R. Kuhne et al.
CLINICAL CANCER RESEARCH (2013)
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Urszula M. Domanska et al.
EUROPEAN JOURNAL OF CANCER (2013)
Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
Luigi Portella et al.
PLOS ONE (2013)
Small Molecule Inhibitors of CXCR4
Bikash Debnath et al.
THERANOSTICS (2013)
Basics and recent advances in peptide and protein drug delivery
Benjamin J. Bruno et al.
THERAPEUTIC DELIVERY (2013)
Dual-Function CXCR4 Antagonist Polyplexes To Deliver Gene Therapy and Inhibit Cancer Cell Invasion
Jing Li et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity
Peng Guo et al.
BIOMATERIALS (2012)
Inhibition of stromal CXCR4 impairs development of lung metastases
Crescenzo D'Alterio et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4
M. P. Rettig et al.
LEUKEMIA (2012)
The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection
L. Patrussi et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer
C. D'Alterio et al.
CURRENT CANCER DRUG TARGETS (2010)
The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
Erik De Clercq
BIOCHEMICAL PHARMACOLOGY (2009)
Liposomal Nanomedicines: An Emerging Field
David B. Fenske et al.
TOXICOLOGIC PATHOLOGY (2008)
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer
Valentina De Falco et al.
CANCER RESEARCH (2007)
Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient
Andreas Fritze et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
Dmitri B. Kirpotin et al.
CANCER RESEARCH (2006)
Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients
A Ottaiano et al.
CLINICAL CANCER RESEARCH (2006)
Human melanoma metastases express functional CXCR4
S Scala et al.
CLINICAL CANCER RESEARCH (2006)
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger et al.
BLOOD (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
R Weissleder et al.
NATURE BIOTECHNOLOGY (2005)
Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4
F Marchesi et al.
CANCER RESEARCH (2004)
Monoclonal antibodies in the treatment of malignancy: Basic concepts and recent developments
RO Dillman
CANCER INVESTIGATION (2001)
分享论文
